ICON plc - Clinical Research Organisation (CRO) for Drug Development

DIALive

Follow the Twitter conversations and trending topics from the 2018 DIA Global Annual Meeting.

ICON and the Intel® Pharma Analytics Platform

ICON announces agreement with Intel® allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials to capture de-identified, objective, high-quality, rich sensory data via sensors and wearable devices.

FIRECREST

Site performance ignited: Digital solutions increase efficiency in clinical trials by driving site performance.

ICON Insights

21 June 2018

Harnessing Blockchain Technology and Digital Disruption

The opportunity for blockchain in healthcare and clinical trials

15 June 2018

The Future of Automation and Digital Transformation in Late Phase Research

Late phase studies are ripe for digitalisation, although not always in the same ways as Phase II and III programs.

14 June 2018

Biostatistics: Using Restricted Mean Survival Time (RMST) in Oncology Trials to Improve Outcomes

Learn how to use biostatistics using RMST in Oncological trials to improve clinical outcomes

11 June 2018

NASH Clearing Clinical Trial Hurdles in Race to $35 billion Market

NASH ranks among the world’s great emerging health threats

07 June 2018

Controlling Logistics Costs Can Significantly Reduce Trial Lab Expenses

ICON has developed a lab logistics program to reduce costs

07 June 2018

Making the Move to Virtual Clinical Trials

Late phase research, once the exception, is becoming the rule. Some post marketing evidence needs can be met with virtual studies, DtP and cyber studies.

30 May 2018

Data-driven Site Selection Aids Accelerated Study Start-Up

There is an increasing demand from sponsors for technology and data-driven solutions to improve site selection, study start- up and patient recruitment.

30 May 2018

Smart Ways to Collect Real-World Data for Device Trials

An insulin injector is significantly safer and easier to use, and therefore leads to fewer complications and better clinical outcomes.

11 April 2018

Scientific Publications: Best Practices in Publication Planning

This is the first posting in a three-part series drawn from ICON’s webinar, “Evolving Best Practices for Working with Authors—Authorship and Beyond.”

Services

Therapeutics

Innovation

Insights

News & Events

About ICON

Improving Pharma R&D Efficiency

Disruptive Innovation – The Impact

Value Based Healthcare

Immuno-Oncology